Open AccessMedicine

J. Lee, J. G. Kim, H. Jung, J. H. Kim, W. Jeong, T. Jeon, J. Kim, Young Il Kim, K. Ryu, S. Kong, Hyoung-il Kim, Hwoong-Yong Jung, Yong Sik Kim, D. Zang, J. Cho, Joon-Oh Park, D. Lim, E. Jung, H. Ahn, H. Kim

2014.6.1Journal of Gastric Cancer

DOI: 10.5230/jgc.2014.14.2.87

tlooto Summary

These guidelines de novo were developed to meet Korean circumstances and requirements to meet patients' view and preferences in the context of Korea and cover diagnostic modalities, treatmentmodalities, and pathologic evaluation.

Abstract

Although gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to those in western countries. However, there are currently no Korean multidisciplinary guidelines for gastric cancer. Experts from related societies developed guidelines de novo to meet Korean circumstances and requirements, including 23 recommendation statements for diagnosis (n=9) and treatment (n=14) based on relevant key questions. The quality of the evidence was rated according to the GRADE evidence evaluation framework: the evidence levels were based on a systematic review of the literature, and the recommendation grades were classified as either strong or weak. The applicability of the guidelines was considered to meet patients' view and preferences in the context of Korea. The topics of the guidelines cover diagnostic modalities (endoscopy, endoscopic ultrasound, and radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, and radiotherapy), and pathologic evaluation. An external review of the guidelines was conducted during the finalization phase.

Citation format

LEE, J., et al. Clinical practice guidelines for gastric cancer in Korea: An evidence-based approach. Journal of Gastric Cancer, 2014, 14: 87–104.